Consistent with previous results, multiple distinct cohorts of melanoma patients who received anti-PD-1, anti-CTLA-4, or combined therapy showed that Bacteroidaceae species have a negative correlation with responsiveness. This evidence concerns the gene PDCD1 and melanoma.